Overview

Neostigmine For Snoring During DISE

Status:
Terminated
Trial end date:
2019-03-19
Target enrollment:
Participant gender:
Summary
The study team is seeking a novel treatment for snoring involving local application of a nerve stimulant medication, neostigmine. In this study, neostigmine will be injected into 5 sites of the soft palate during a standard procedure, drug-induced sleep endoscopy, to evaluate the effect on snoring.
Phase:
Early Phase 1
Details
Lead Sponsor:
Emory University
Treatments:
Neostigmine